Detalles de la búsqueda
1.
PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology.
Int J Mol Sci
; 22(8)2021 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33923839
2.
Relevance of 18F-DOPA visual and semi-quantitative PET metrics for the diagnostic of Parkinson disease in clinical practice: a machine learning-based inference study.
EJNMMI Res
; 13(1): 13, 2023 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780091
3.
Head-to-Head Comparison Between Rabbit Sign and EANM/SNMMI Criteria for the 18F-DOPA Visual Assessment of Parkinsonian Syndromes in PET/MRI: A Multiple Expert-Based and Blinded Controlled Study.
Clin Nucl Med
; 48(2): 112-118, 2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36607361
4.
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer.
Ann Nucl Med
; 34(12): 968-974, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070295
5.
Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab.
Cancers (Basel)
; 12(8)2020 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32785166
6.
Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST.
EJNMMI Res
; 9(1): 8, 2019 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30694399
7.
Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab.
Oncoimmunology
; 8(5): e1580128, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31069139
8.
Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanoma.
Immunotherapy
; 11(12): 1005-1013, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31304833
Resultados
1 -
8
de 8
1
Próxima >
>>